ទំព័រដើម › មហារីកស៊ុត › ប៉ែនស៊ីលវ៉ានី › Philadelphia
ការសាកល្បងគ្លីនិកសម្រាប់ មហារីកស៊ុត នៅក្នុង Philadelphia, PA
ការសិក្សាចំនួន 44 សម្រាប់ មហារីកស៊ុត កំពុងរកអ្នកចូលរួមនៅតាមទីតាំងក្នុង និងជុំវិញ Philadelphia (ក្នុងចម្ងាយប្រហែល 30 ម៉ាយ)។ បើកការសិក្សាមួយដើម្បីមើលថាតើនរណាអាចចូលរួម និងរបៀបទំនាក់ទំនងទៅកាន់ក្រុមការងារសិក្សា។
អត្ថបទសិក្សាផ្លូវការ (អង់គ្លេស)
កំពុងរកអ្នកចូលរួមសម្រាប់ការសិក្សាមួយនៅទីនេះ? លេចធ្លោនៅផ្នែកខាងលើនៃទំព័រនេះ — $99 សម្រាប់ 30 ថ្ងៃ →
Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity
កំពុងជ្រើសរើសដំណាក់កាល 2/3
- Thomas Jefferson University Hospital, Philadelphia
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
កំពុងជ្រើសរើសដំណាក់កាល 2
- Pennsylvania Hospital, Philadelphia
- Thomas Jefferson University Hospital, Philadelphia
- Fox Chase Cancer Center, Philadelphia
- និង 4 ទៀត
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
កំពុងជ្រើសរើសដំណាក់កាល 1/2
- Abramson Cancer Center of the University of Pennsylvania, Philadelphia
A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
កំពុងជ្រើសរើសដំណាក់កាល 1
- Sidney Kimmell Cancer Center - Jefferson Health, Philadelphia
Risk Reducing Salpingectomy With Delayed Oophorectomy as an Alternative to Risk- Reducing Salpingo-oophorectomy in High Risk-Women to Assess the Safety of Prevention - US Cohort Study
កំពុងជ្រើសរើស
- University of Pennsylvania, Philadelphia
A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
កំពុងជ្រើសរើសដំណាក់កាល 2
- University of Pennsylvania - Perelman Center for Advanced Medicine /ID# 275612, Philadelphia
A Study of Azenosertib (ZN-c3) in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer
កំពុងជ្រើសរើសដំណាក់កាល 2
- Site 0232 - University of Pennsylvania, Philadelphia
- Site 0178 - Thomas Jefferson University, Philadelphia
Study of AVZO-021 in Patients With Advanced Solid Tumors
កំពុងជ្រើសរើសដំណាក់កាល 1/2
- Avenzo Therapeutics Recruiting Site, Philadelphia
DESTINY-PANTUMOUR04
កំពុងជ្រើសរើសការសិក្សាសង្កេត
- Research Site, Philadelphia
A Study to Find Out How Safe REGN5668 is and How Well it Works In Adult Women When Given With Either Cemiplimab, or Cemiplimab + Fianlimab, or Ubamatamab
កំពុងជ្រើសរើសដំណាក់កាល 1/2
- Perelman School of Medicine at the University of Pennsylvania, Philadelphia
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
កំពុងជ្រើសរើសដំណាក់កាល 3
- University of Pennsylvania Hospital, Philadelphia
- Jefferson Health Honickman Center, Philadelphia
- Asplundh Cancer Pavilion, Willow Grove · ឆ្ងាយ 13 ម៉ាយ
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
កំពុងជ្រើសរើសដំណាក់កាល 1
- University of Pennsylvania, Philadelphia
- Fox Chase Cancer Center, Philadelphia
A Study to Assess Adverse Events and Change in Disease Activity of Multiple Treatment Combinations With Intravenous Mirvetuximab Soravtansine in Adult Participants With Ovarian Cancer
កំពុងជ្រើសរើសដំណាក់កាល 2
- Penn Medicine University of Pennsylvania Health System /ID# 277963, Philadelphia
Prehabilitation in High-risk Oncologic Surgery
កំពុងជ្រើសរើស
- Fox Chase Cancer Center - Philadelphia, Philadelphia
BI-1808 as a Single Agent and With Pembrolizumab (KEYTRUDA® ) in Treatment of Advanced Malignancies(Keynote-D20)
កំពុងជ្រើសរើសដំណាក់កាល 1/2
- University of Pennsylvania, Philadelphia
A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021)
កំពុងជ្រើសរើសដំណាក់កាល 3
- Hospital of the University of Pennsylvania ( Site 0071), Philadelphia
Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
កំពុងជ្រើសរើសដំណាក់កាល 3
- Lankenau Medical Center, Wynnewood · ឆ្ងាយ 7 ម៉ាយ
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
កំពុងជ្រើសរើសការសិក្សាសង្កេត
- University of Pennsylvania, Philadelphia
FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors
កំពុងជ្រើសរើសដំណាក់កាល 1
- Thomas Jefferson University, Sidney Kimmel Cancer Center, Philadelphia
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
កំពុងជ្រើសរើសដំណាក់កាល 1/2
- Children's Hospital of Philadelphia, Philadelphia
A Phase 1 Study of LNCB74 in Advanced Solid Tumors
កំពុងជ្រើសរើសដំណាក់កាល 1
- Sidney Kimmel Comprehensive Center at Jefferson, Philadelphia
A Study of MUC16-Directed Antibody Drug Conjugate HWK-016 in Participants With Advanced Solid Tumors.
កំពុងជ្រើសរើសដំណាក់កាល 1
- SCRI - Sydney Kimmel Cancer Center - Jefferson Health, Philadelphia
A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
កំពុងជ្រើសរើសដំណាក់កាល 1
- Normunity Investigational Site, Philadelphia
- Normunity Investigational Site, Philadelphia
The Appendix Cancer PMP Research Foundation Natural History Study/Patient Registry
កំពុងជ្រើសរើសការសិក្សាសង្កេត
- ACPMP, Springfield · ឆ្ងាយ 8 ម៉ាយ
A Study of Azenosertib (ZN-c3) Versus Investigator's Choice Chemotherapy in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Primary Peritoneal, or Fallopian Tube Cancers Positive for Cyclin E1 Protein Expression
កំពុងជ្រើសរើសដំណាក់កាល 3
- Site 0109, Philadelphia
- Site 0113, Philadelphia
- Site 0114, Willow Grove · ឆ្ងាយ 13 ម៉ាយ
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
កំពុងជ្រើសរើស
- University of Pennsylvania/Abramson Cancer Center, Philadelphia
- Fox Chase Cancer Center, Philadelphia
- Lankenau Medical Center, Wynnewood · ឆ្ងាយ 7 ម៉ាយ
- និង 5 ទៀត
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
កំពុងជ្រើសរើសដំណាក់កាល 3
- University of Pennsylvania/Abramson Cancer Center, Philadelphia
- Pennsylvania Hospital, Philadelphia
- Thomas Jefferson University Hospital, Philadelphia
- និង 5 ទៀត
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
កំពុងជ្រើសរើសដំណាក់កាល 1/2
- University of Pennsylvania / Abramson Cancer Center, Philadelphia
- Thomas Jefferson University, Sidney Kimmel Cancer Center, Clinical Research Organization, Philadelphia
A Study of Raludotatug Deruxtecan (R-DXd) in Subjects With Platinum-resistant, High-grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
កំពុងជ្រើសរើសដំណាក់កាល 2/3
- Perelman School of Medicine at the University of Pennsylvania, Philadelphia
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
កំពុងជ្រើសរើសដំណាក់កាល 2
- Thomas Jefferson University, Philadelphia
Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors
កំពុងជ្រើសរើសដំណាក់កាល 1
- Investigative Site #109, Philadelphia
An Evaluation of Maintenance Therapy Combination Mirvetuximab Soravtansine and Olaparib
កំពុងជ្រើសរើសដំណាក់កាល 2
- University of Pennsylvania Health System, Perelman Center for Advanced Medicine, Philadelphia
SynKIR-110 for Mesothelin Expressing Ovarian Cancer, Cholangiocarcinoma or Mesothelioma
កំពុងជ្រើសរើសដំណាក់កាល 1
- University of Pennsylvania, Philadelphia
Study of NMS-03305293 in Adult Patients With Relapsed Ovarian Cancer
កំពុងជ្រើសរើសដំណាក់កាល 1
- Penn Medicine - Perelman Center for Advanced Medicine, Philadelphia
ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors
កំពុងជ្រើសរើសដំណាក់កាល 1/2
- University of Pennsylvania, Perelamn Center for Advanced Medicine, Philadelphia
- Thomas Jefferson University, Honickman Center, Philadelphia
- Fox Chase Cancer Center, Philadelphia
Heated Intraperitoneal Chemotherapy Followed by Niraparib for Ovarian, Primary Peritoneal and Fallopian Tube Cancer
កំពុងជ្រើសរើសដំណាក់កាល 3
- Lankenau Medical Center/Mainline Medical Center, Wynnewood · ឆ្ងាយ 7 ម៉ាយ
- Jefferson Abington Hospital, Abington · ឆ្ងាយ 12 ម៉ាយ
- Asplundh Cancer Pavilion, Willow Grove · ឆ្ងាយ 13 ម៉ាយ
TUBectomy With Delayed Oophorectomy in High Risk Women to Assess the Safety of Prevention
កំពុងជ្រើសរើស
- Hospital of the University of Pennsylvania, Philadelphia
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
កំពុងជ្រើសរើសដំណាក់កាល 1/2
- Thomas Jefferson University, Sidney Kimmel Comprehensive Cancer Center, Philadelphia
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
កំពុងជ្រើសរើសដំណាក់កាល 1
- Thomas Jefferson University, Sidney Kimmel Cancer Center, Philadelphia
- Fox Chase Cancer Center, Philadelphia
Healthy Volunteers Study
កំពុងជ្រើសរើសការសិក្សាសង្កេតស្វាគមន៍អ្នកស្ម័គ្រចិត្តដែលមានសុខភាពល្អ
- Abramson Cancer Center of the University of Pennsylvania, Philadelphia
CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.
កំពុងជ្រើសរើសដំណាក់កាល 2
- University of Pennsylvania, Philadelphia
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
កំពុងជ្រើសរើសការសិក្សាសង្កេត
- Massive Bio SYNERGY-AI site, Philadelphia
Study of Senaparib in Combination With Temozolomide in ARID1A Mutation Associated Ovarian Cancer
កំពុងជ្រើសរើសដំណាក់កាល 2
- University of Pennsylvania/Abramson Cancer Center, Philadelphia
Study of Tumor Tissue Samples From Patients Who Have Undergone Surgery for Advanced Stage III or Stage IV Ovarian Epithelial Cancer
កំពុងជ្រើសរើសការសិក្សាសង្កេត
- Gynecologic Oncology Group, Philadelphia
ការសាកល្បងសម្រាប់ មហារីកស៊ុត នៅក្នុងទីក្រុងផ្សេងទៀត
- Houston, TXការសិក្សា 89
- New York City, NYការសិក្សា 69
- Boston, MAការសិក្សា 61
- Los Angeles, CAការសិក្សា 50
- Nashville, TNការសិក្សា 49
- Arlington, VAការសិក្សា 46
- Columbus, OHការសិក្សា 39
- St. Louis, MOការសិក្សា 38
- Chicago, ILការសិក្សា 36
- San Antonio, TXការសិក្សា 31
- Cleveland, OHការសិក្សា 30
- Pittsburgh, PAការសិក្សា 30
ការសិក្សាផ្សេងទៀតនៅក្នុង Philadelphia
- មហារីក (គ្រប់ប្រភេទ)ការសិក្សា 59
- មហារីកទ្រូងការសិក្សា 56
- Non-Small Cell Lung Cancerការសិក្សា 51
- មហារីកដែលរីករាលដាលការសិក្សា 46
- មហារីកតូចការសិក្សា 44
- មហារីកពោះវៀនធំ និងទ្វារមាសការសិក្សា 44
- មហារីកសួតការសិក្សា 36
- ជំងឺលីកូសេមីមីអេឡូអ៊ីដបន្ទាន់ការសិក្សា 34
- បេះដូងខ្សោយការសិក្សា 31
- មហារីកស្រទាប់ស្បែកស្តីការសិក្សា 28
- ភាពសោកសៅការសិក្សា 26
- មហារីកតំបក់ការសិក្សា 26
ពី ClinicalTrials.gov, ទិន្នន័យទទួលបាននៅថ្ងៃ 6 តុលា 2026។ ការសិក្នានីមួយៗកំណត់លក្ខខណ្ឌលក្ខណៈសម្បត្តិរបស់ខ្លួន; ក្រុមការងារសិក្សាកំណត់ថាតើនរណាអាចចូលរួម។